Anna Särnefält CEPI

Anna Särnefält joined Coalition for Epidemic Preparedness Innovations, CEPI, as CMC Lead at the beginning of 2020. She previously worked eight years as Team Leader and Senior Scientist within process development of viral vectored vaccines at Bavarian Nordic A/S and has 12 years’ experience within antibody drug discovery from BioInvent AB following her M. Sc. degree in Chemical Engineering; Biotechnology from The Faculty of Engineering at Lund University, Sweden.